These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38021852)

  • 1. Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Carcinoma Using Image-Guided Clip Placement.
    Pandurangappa V; Paruthy SB; Jamwal R; Singh A; Tanwar S; Kumar D; Pal S; Mohan SK; Das A; Trs PR
    Cureus; 2023 Oct; 15(10):e47763. PubMed ID: 38021852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Subtypes As Emerging Predictors of Clinicopathological Response to Neoadjuvant Chemotherapy (NACT) in Locally Advanced Breast Cancer (LABC): A Single-Centre Experience in Western India.
    Sharma S; Rathore SS; Verma V; Kalyan M; Singh N; Irshad I
    Cureus; 2022 May; 14(5):e25229. PubMed ID: 35755569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional therapy of locally advanced breast cancer: a clinical practice guideline.
    Brackstone M; Fletcher GG; Dayes IS; Madarnas Y; SenGupta SK; Verma S;
    Curr Oncol; 2015 Mar; 22(Suppl 1):S54-66. PubMed ID: 25848339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of short-term efficacy as defined by RECIST and pathological response of neoadjuvant chemotherapy comprised paclitaxel and cisplatin followed by radical surgery in patients with locally advanced cervical cancer: A prospective observational study.
    He Y; Zhao Q; Geng YN; Yang SL; Li XM; Finas D; Yin CH; Wu YM
    Medicine (Baltimore); 2018 Jun; 97(22):e10913. PubMed ID: 29851821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Study on Clinical and Pathological Responses to Neoadjuvant Chemotherapy in Breast Carcinoma.
    Kunnuru SKR; Thiyagarajan M; Martin Daniel J; Singh K B
    Breast Cancer (Dove Med Press); 2020; 12():259-266. PubMed ID: 33262647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility study of safe breast conservation in large and locally advanced cancers with use of radiopaque markers to mark pre-neoadjuvant chemotherapy tumor margins.
    Aggarwal V; Agarwal G; Lal P; Krishnani N; Mishra A; Verma AK; Mishra SK
    World J Surg; 2008 Dec; 32(12):2562-9. PubMed ID: 18030518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience.
    Bhattacharyya T; Sharma SC; Yadav BS; Singh R; Singh G
    Indian J Med Paediatr Oncol; 2014 Jul; 35(3):215-20. PubMed ID: 25336793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of breast conservation surgery in locally advanced breast cancer downstaged by neoadjuvant chemotherapy: a study in mastectomy specimens using simulation lumpectomy.
    Viswambharan JK; Kadambari D; Iyengar KR; Srinivasan K
    Indian J Cancer; 2005; 42(1):30-4. PubMed ID: 15805689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation and Validation of Neo-Adjuvant Response Index (NRI) and It's Correlation with Various Predictive Biomarkers and RECIST in Locally Advanced Breast Cancer.
    Bamal R; Chintamani ; Tandon M; Mittal MK; Saxena S
    Indian J Surg Oncol; 2014 Sep; 5(3):171-7. PubMed ID: 25419059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Ki-67 Really Useful as a Predictor for Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer?
    Dave S; Choudhury A; Alurkar SS; Shah AM
    Indian J Surg Oncol; 2024 Mar; 15(1):44-52. PubMed ID: 38511030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on clinico-pathological assessment of response to neoadjuvant chemotherapy in breast carcinoma.
    Mohapatra M; Sarma YS
    J Cancer Res Ther; 2020; 16(6):1419-1425. PubMed ID: 33342807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of response to neo-adjuvant chemotherapy in patients with locally advanced breast cancer with emphasis on pathological complete response.
    Narendra H; Thomas J; Ray S; Fernandes DJ
    Indian J Cancer; 2014; 51(4):587-92. PubMed ID: 26842205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally Advanced Breast Cancer: Response Evaluation to Neoadjuvant Chemotherapy by Clinico-Histopathological Parameters and Molecular Imaging.
    Jain AK
    Indian J Surg Oncol; 2023 Jun; 14(2):279-287. PubMed ID: 37324312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI.
    Cheung YC; Chen SC; Su MY; See LC; Hsueh S; Chang HK; Lin YC; Tsai CS
    Breast Cancer Res Treat; 2003 Mar; 78(1):51-8. PubMed ID: 12611457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Response to Neoadjuvant Chemotherapy Using 18F FDG PET-CT in Patients with Locally Advanced Breast Cancer.
    Hulikal N; Gajjala SR; Kalawat T; Kadiyala S; Kottu R
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):93-98. PubMed ID: 31983170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Tc99m-Sestamibi scintimammography in assessing response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Mittal BR; Singh RK; Kumari S; Manohar K; Bhattacharya A; Singh G
    Indian J Nucl Med; 2012 Oct; 27(4):221-5. PubMed ID: 24019650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast enhanced ultrasound quantitative parameters for assessing neoadjuvant chemotherapy response in patients with locally advanced breast cancer.
    Sharma A; Grover SB; Mani C; Ahluwalia C
    Br J Radiol; 2021 May; 94(1121):20201160. PubMed ID: 33860674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locally advanced thymoma; does neoadjuvant chemotherapy make a difference?
    Abdel Jalil R; Abdallah FA; Obeid Z; Harb AK; Abou Chaar MK; Shannies TB; El-Edwan A; Haddad H; Ghraibeh A; Abu-Shanab A
    J Cardiothorac Surg; 2023 Aug; 18(1):245. PubMed ID: 37592291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
    Liu K; Li G; Fan C; Zhou C; Li J
    Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.